AbbVie (ABBV) Short-Term Debt issuances (2013 - 2026)
AbbVie (ABBV) reported Short-Term Debt issuances of -$499.0 million for Q1 2026, down 131.32% year-over-year from $1.6 billion in Q1 2025, and up 88.39% on a QoQ basis from -$4.3 billion in Q4 2025.
AbbVie (ABBV) has 10 years of Short-Term Debt issuances data on file, last reported at -$499.0 million in Q1 2026.
- Quarterly Short-Term Debt issuances fell 131.32% year-over-year to -$499.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.6 billion (down 131.9% YoY) and the FY2025 annual result came in at $499.0 million, changed N/A from the prior year.
- Short-Term Debt issuances advanced to -$499.0 million in Q1 2026 per ABBV's latest filing, from -$4.3 billion in the prior quarter.
- Across five years, Short-Term Debt issuances topped out at $3.2 billion in Q3 2025 and bottomed at -$4.3 billion in Q4 2025.
- The 3-year median for Short-Term Debt issuances is $1.6 billion (2025), against an average of $485.7 million.
- The widest annual swing landed in 2025, when Short-Term Debt issuances surged 91.12%; it then sank 131.32% in 2026.
- Tracing ABBV's Short-Term Debt issuances over 3 years: stood at $1.7 billion in 2024, then sank by 352.88% to -$4.3 billion in 2025, then soared by 88.39% to -$499.0 million in 2026.
- Per Business Quant, the three latest ABBV Short-Term Debt issuances figures stand at -$499.0 million (Q1 2026), -$4.3 billion (Q4 2025), and $3.2 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Short-Term Debt issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | 1.78 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 12.44 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | -499.00 Mn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | 1.06 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | - |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | - |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | -127.00 Mn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | 321.00 Mn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -499.00 Mn |
| Mar 31, 2026 | -499.00 Mn |
| Dec 31, 2025 | -4.30 Bn |
| Dec 31, 2025 | -4.30 Bn |
| Sep 30, 2025 | 3.25 Bn |
| Sep 30, 2025 | 3.25 Bn |
| Jun 30, 2025 | -44.00 Mn |
| Jun 30, 2025 | -44.00 Mn |
| Mar 31, 2025 | 1.59 Bn |
| Mar 31, 2025 | 1.59 Bn |
| Sep 30, 2024 | 1.70 Bn |
| Sep 30, 2024 | 1.70 Bn |
| Jun 30, 2024 | 1.70 Bn |
| Jun 30, 2024 | 1.70 Bn |
| Sep 30, 2019 | -306.00 Mn |
| Sep 30, 2019 | -306.00 Mn |
| Jun 30, 2019 | -193.00 Mn |
| Jun 30, 2019 | -193.00 Mn |
| Mar 31, 2019 | -200.00 Mn |
| Mar 31, 2019 | -200.00 Mn |
| Dec 31, 2018 | 3.40 Bn |
| Dec 31, 2018 | 3.40 Bn |
| Sep 30, 2018 | -511.00 Mn |
| Sep 30, 2018 | -511.00 Mn |
| Jun 30, 2018 | 144.00 Mn |
| Jun 30, 2018 | 144.00 Mn |
| Mar 31, 2018 | -33.00 Mn |
| Mar 31, 2018 | -33.00 Mn |
| Dec 31, 2017 | -400.00 Mn |
| Dec 31, 2017 | -400.00 Mn |
| Sep 30, 2017 | 423.00 Mn |
| Sep 30, 2017 | 423.00 Mn |
| Jun 30, 2017 | -23.00 Mn |
| Jun 30, 2017 | -23.00 Mn |
| Mar 31, 2017 | 23.00 Mn |
| Mar 31, 2017 | 23.00 Mn |
| Dec 31, 2016 | 383.00 Mn |
| Dec 31, 2016 | 383.00 Mn |
| Sep 30, 2016 | -494.00 Mn |
| Sep 30, 2016 | -494.00 Mn |
| Jun 30, 2016 | 94.00 Mn |
| Jun 30, 2016 | 94.00 Mn |
| Mar 31, 2016 | -6.00 Mn |
| Mar 31, 2016 | -6.00 Mn |
| Dec 31, 2015 | -354.00 Mn |
| Dec 31, 2015 | -354.00 Mn |
| Sep 30, 2015 | 760.00 Mn |
| Sep 30, 2015 | 760.00 Mn |
| Jun 30, 2015 | -569.00 Mn |
| Jun 30, 2015 | -569.00 Mn |
| Mar 31, 2015 | 144.00 Mn |
| Mar 31, 2015 | 144.00 Mn |
| Dec 31, 2014 | 124.00 Mn |
| Dec 31, 2014 | 124.00 Mn |
| Sep 30, 2014 | 50.00 Mn |
| Sep 30, 2014 | 50.00 Mn |
| Jun 30, 2014 | 248.00 Mn |
| Jun 30, 2014 | 248.00 Mn |
| Mar 31, 2014 | -410.00 Mn |
| Mar 31, 2014 | -410.00 Mn |
| Dec 31, 2013 | 2.00 Mn |
| Dec 31, 2013 | 2.00 Mn |
| Sep 30, 2013 | 1.00 Mn |
| Sep 30, 2013 | 1.00 Mn |
| Jun 30, 2013 | -3.00 Mn |
| Jun 30, 2013 | -3.00 Mn |
| Mar 31, 2013 | -601.00 Mn |
| Mar 31, 2013 | -601.00 Mn |